Transplacental digoxin therapy for fetal tachyarrhythmia with multiple evaluation systems

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 11, 2011, Pages 1378-1383

  Zhou, Kaiyu ^a   Hua, Yimin ^a   Zhu, Qi ^b   Liu, Hanmin ^a   Yang, Sen ^a   Zhou, Rong ^b   Guo, Nan ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

atrial flutter; evaluation; Fetal tachyarrhythmia; supraventricular tachycardia; transplacental digoxin therapy

Indexed keywords

DIGOXIN; PROPRANOLOL;

ARTERY RESISTANCE; ARTICLE; CASE REPORT; DIGOXIN BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; ECHOCARDIOGRAPHY; FEMALE; FETUS; FETUS DISEASE; FETUS ELECTROCARDIOGRAPHY; HEART ATRIUM FLUTTER; HUMAN; MALE; PLACENTAL TRANSFER; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; DIGOXIN; ECHOCARDIOGRAPHY; FEMALE; FETAL DISEASES; FETAL MONITORING; FETAL MOVEMENT; GESTATIONAL AGE; HEART RATE, FETAL; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; TACHYCARDIA; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 80053935929     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.554924     Document Type: Article

References (22)

1. Cuneo BF. Outcome of fetal cardiac defects. Curr Opin Pediatr 2006;18:490-496. (Pubitemid 44401284)
2. Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004; 25:234-251. (Pubitemid 38725508)
3. Lopriore E, Aziz MI, Nagel HT, Blom NA, Rozendaal L, Kanhai HH. Long-term neurodevelopmental outcome after fetal arrhythmia. Am J Obstet Gynecol 2009;201:e1-e5.
4. Sekar P. The role of fetal echocardiography in fetal intervention: a symbiotic relationship. Clin Perinatol 2009,36:301-327.
5. Bruch C, Schmermund A, Marin D, Katz M, Bartel T, Schaar J, Erbel R. Tei index in patients with mild-to-moderate congestive failure. Eur Heart J 2000;21:1888-1895.
6. Misumi I, Harada E, Doi H, Hayasaki T, Kajihara E, Motoshima R, Iwaihara H. Tei index evaluated by M-mode echocardiography in patients with dilated cardiomyopathy. J Cardiol 2002;39:85-91. (Pubitemid 40754210)
7. Makhseed M. Middle cerebral artery to umbilical artery resistance index ratio in the prediction of neonatal outcome. Int J Gynaecol Obstet 2000;71:119-125.
8. Tan AE. Umbilical artery resistance index in diabetic pregnancies: the associations with fetal outcome and neonatal septal hypertrophic cardiomyopathy. J Obstet Gynaecol Res 2005;31: 296-301. (Pubitemid 41192564)
9. Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med 2005;10:542-552. (Pubitemid 41562787)
10. Hofstaetter C, Hansmann M, Eik-nes SH, Huhta JC. A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med 2006;19:407-413. (Pubitemid 44272914)
11. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003;89:913-917. (Pubitemid 36920819)
12. Mozas J, Miranda JA, Barranco M. Treatment of fetal supraventricular tachycardia with maternal administration of digoxin. Int J Gynaecol Obstet 1995;50:293-294.
13. Martijn AO, Jopje MR, Tessa FF, Ambachtsheer EB, Stoutenbeek P, Gerard HA, Meijboom EJ. Treatment of fetal tachycardia with sotalol transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 2003;42:765-770. (Pubitemid 37000201)
14. Dhaval P, Bettina C, Regina V, Juha R, Jenny L, Huhta J, et al. Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score. J Matern Fetal Neonatal Med 2008;21:477-482. (Pubitemid 352000666)
15. Darbar D. Pharmacogenetics of antiarrhythmic therapy. Expert Opin Pharmacother 2006;7:1583-1590. (Pubitemid 44209602)
16. Poolsup N. Pharmacogenetics and psychopharmacotherapy. J Clin Pharm Ther 2000;25:197-220.
17. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation 2008; 118:1383-1393.
18. Matthew D. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 2001;15:819-826.
19. Lisowski LA, Verheijen PM, Benatar AA, Soyeur DJ, Stoutenbeek P, Brenner JI, Kleinman CS, Meijboom EJ. Atrial flutter in the perinatal age group diagnosis, management and outcome. J Am Coll Cardiol 2000;35:771-777. (Pubitemid 30167036)
20. Oudijk MA, Ruskamp JM, Ambachtsheer BE, Ververs TF, Stoutenbeek P, Visser GH. Drug treatment of fetal tachycardias. Paediatr Drugs 2002;4:49-63. (Pubitemid 34208346)
21. Amiel TC. Fetal adaptation to stress. I. Acceleration of fetal maturation and earlier birth triggered by placental insufficiency in humans. Early Hum Dev 2004;78:15-27.
22. Falkensammer F, James P, Huhta JC. Fetal congestive heart failure: correlation of Tei-index and Cardiovascular-score. J Perinat Med 2001;29:390-398. (Pubitemid 33608021)